Cargando…
Many-to-one comparisons after safety selection in multi-arm clinical trials
In phase II platform trials, ‘many-to-one’ comparisons are performed when K experimental treatments are compared with a common control to identify the most promising treatment(s) to be selected for Phase III trials. However, when sample sizes are limited, such as when the disease of interest is rare...
Autores principales: | Hlavin, Gerald, Hampson, Lisa V., Koenig, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484516/ https://www.ncbi.nlm.nih.gov/pubmed/28651023 http://dx.doi.org/10.1371/journal.pone.0180131 |
Ejemplares similares
-
Designing multi‐arm multi‐stage clinical trials using a risk–benefit criterion for treatment selection
por: Jaki, Thomas, et al.
Publicado: (2015) -
Evidence, eminence and extrapolation
por: Hlavin, Gerald, et al.
Publicado: (2016) -
Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013) -
One or many?
por: Antonella Del Rosso
Publicado: (2013) -
One for many
por: Greco, Peter M.
Publicado: (2020)